Skip to content
Search

Latest Stories

'UK braced for 100,000 daily Covid cases'

Using inoculations as "wall of defence", the UK announced plans to further relax to its pandemic curbs on Tuesday despite warning that the number of daily new cases is set to more than treble to reach 100,000.

From August 16, adults in England who have received both doses of a coronavirus vaccine will no longer need to self-isolate if they are in close contact with a positive case, health secretary Sajid Javid said.


Instead they will need to take a test and isolate only if they are found to be positive, he told parliament.

The same rules will apply to under 18s, who are not yet receiving vaccinations in Britain, Javid added.

The rules will come in ahead of the return to school for the September term, after months in which entire classes have been sent home to the fury of parents.

The health secretary was updating MPs a day after prime minister Boris Johnson revealed plans to lift most of England's coronavirus restrictions, including face masks and social

distancing, from July 19, urging personal responsibility rather than government edict.

As part of devolved administration, Scotland, Wales and Northern Ireland set their own health policy and are moving more slowly.

Johnson had initially aimed for a full reopening on June 21, but was forced to push back the

date because of a surge in the highly contagious Delta variant.

That variant now accounts for nearly all new Covid-19 cases in Britain, and daily infection

rates have soared to nearly 30,000 in recent days.

Javid said that figure was likely to reach 50,000 a day by July 19, and as high as 100,000 later in the summer.

But the vaccination campaign has "weakened" the link with hospitalisations and deaths, he

stressed to MPs, saying that inoculations are "our wall of defence".

More than 86 percent of adults in the UK have received at least one jab, with 64 percent fully vaccinated, according to NHS data.

He also responded to media reports that three batches of the AstraZeneca jab made in India have not been approved for use in the EU, potentially hindering summer travel for British recipients of those doses.

Britain has not been using the Covishield-branded jab made by the Serum Institute of India, and the government is in "intensive discussions" with Brussels on the issue, Javid said.

More For You

GP surgery upgrades for annual appointments

The surgeries will have additional space to “see more patients, boost productivity and improve patient care”

Pic credit: iStock

GP surgery upgrades to create 8.3 million more annual appointments

Over 1,000 GP surgeries will have their premises modernised to meet the needs of a further 8.3 million appointments each year, the government has announced.

Backed by a cash injection of over £102 million, the surgeries will have additional space to “see more patients, boost productivity and improve patient care”.

Keep ReadingShow less
Wales boosts funding for pharmacy-led UTI and sore throat test services

The sore throat test (STTT) and treat service will be widely available

Pic credit: istock

Welsh pharmacies receive funding boost for clinical services

Two key clinical services will be available in 99 per cent of community pharmacies across Wales after a boost in funding.

The sore throat test (STTT) and treat service and the urinary tract infection (UTI) service have both benefitted from contractual negotiations between the Welsh Government and Community Pharmacy Wales (CPW).

Keep ReadingShow less
Paul Bennett
Paul Bennett, CEO, Royal Pharmaceutical Society
Paul Bennett, CEO, Royal Pharmaceutical Society

Pharmacists need to take advantage of independent prescribing pathways, says Bennett

Independent prescribing will be a “significant point” in the history of community pharmacy, according to Royal Pharmaceutical Society chief executive Paul Bennett.

Last month, the RPS announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

Keep ReadingShow less
Community Pharmacy Scotland secures £10m reimbursement uplift amid ongoing negotiations

Negotiations continue on the Global Sum element of remuneration.

Getty Images

Community Pharmacy Scotland secures £120m reimbursement deal for 2025/26

Community Pharmacy Scotland (CPS) has accepted the Scottish government’s initial financial offer for the 2025/26 fiscal year, securing a guaranteed minimum reimbursement of £120 million for community pharmacies — up from £110 million from 2024/25.

The agreement marks the first phase of ongoing negotiations surrounding community pharmacy funding for the upcoming financial year.

Keep ReadingShow less